AREV Life Sciences Global Corp.
AREV
CNSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -178.10K | -340.90K | -856.50K | -1.13M | -794.70K |
| Total Depreciation and Amortization | 52.00K | 66.60K | 82.50K | 96.70K | 103.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -111.20K | -85.50K | 139.90K | 155.20K | -218.00K |
| Change in Net Operating Assets | 124.70K | 258.00K | 518.60K | 659.00K | 612.60K |
| Cash from Operations | -112.60K | -101.80K | -115.60K | -223.30K | -296.40K |
| Capital Expenditure | 9.00K | 9.00K | -500.00 | -22.00K | -31.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -361.20K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.10K | -10.10K | -10.10K | -10.10K | -10.60K |
| Cash from Investing | -1.10K | -1.10K | -10.60K | -32.10K | -402.80K |
| Total Debt Issued | 108.00K | 117.00K | 33.10K | 5.40K | 328.30K |
| Total Debt Repaid | -- | -13.70K | -27.40K | -41.10K | 121.90K |
| Issuance of Common Stock | 31.50K | 31.50K | 178.20K | 202.00K | 422.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103.70K | 100.10K | 141.80K | 131.20K | 690.80K |
| Foreign Exchange rate Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -800.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.00K | -2.80K | 15.60K | -124.20K | -9.20K |
